OXcan raises $11m to develop liquid biopsy tests for early cancer detection
Oxford Cancer Analytics (OXcan) has secured $11m in Series A funding for the development of its liquid biopsy blood tests…
Oxford Cancer Analytics (OXcan) has secured $11m in Series A funding for the development of its liquid biopsy blood tests…
The US Food and Drug Administration (FDA) has granted 510(k) clearance for Inogen’s SIMEOX 200 Airway Clearance Device for individuals…
Nyxoah has introduced its Genio neurostimulator, which is intended for obstructive sleep apnoea (OSA) treatment in England, with the first…
Beyond Air has gained CE mark approval for its LungFit PH system, permitting the marketing of the device within the…
Plus Therapeutics subsidiary CNSide Diagnostics has reported data from the multi-centre FORESEE trial, which highlights the CNSide cerebrospinal fluid (CSF)…
Sheba Medical Center's innovation arm, Accelerate, Redesign, and Collaborate (ARC), has partnered with Roche to advance the diagnosis and treatment…
Medical technology company SoundHealth has launched SONUCheck, a vocal analysis feature in the SONU app that uses AI to measure…
Researchers at the Mayo Clinic in the US have developed a new testing strategy aimed at improving mesothelioma cancer deoxyribonucleic…
PrognomiQ has closed its Series D financing round, securing $34m, for advancing the development of an early lung cancer detection…
Baxter International has launched its next-generation airway clearance system, The Vest advanced pulmonary experience (APX) system, aimed at supporting therapy…